Where to inject? study tests blood thinner effectiveness in obese patients
NCT ID NCT07213713
Summary
This study aims to find the best place to inject a common blood thinner (enoxaparin) in people with severe obesity. Researchers will compare injections in the arm versus the abdomen to see which location provides more consistent drug levels in the blood. The goal is to better prevent dangerous blood clots in this high-risk group.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENOUS THROMBOEMBOLISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.